Nodal Stage of Surgically Resected Non-Small Cell Carcinoma of the Lung and Its Effect on Recurrence Pattern and Survival.
Satvik Ramakrishna,John M. Varlotto,Malcolm M. DeCamp,Nengliang Yao,Abram Recht,John Charles Flickinger,Adin‐Cristian Andrei,Jennifer Toth,Michael F. Reed,Allan Lipton,K.A. Higgins,Xiyu Zheng,Julia Shelkey,Laura N. Medford‐Davis,Chris R. Kelsey
DOI: https://doi.org/10.1200/jco.2014.32.15_suppl.7552
IF: 45.3
2014-01-01
Journal of Clinical Oncology
Abstract:7552 Background: Current NCCN guidelines recommend post-operative radiotherapy (PORT) for patients with resected non-small cell lung cancer (NSCLC) with N2-involvement. We investigated the relationship between nodal-stage and local-regional recurrence (LR), distant recurrence (DR) and overall survival (OS) for patients having an R0 resection. Methods: A multi-institutional database of consecutive patients undergoing R0resection for Stages I-IIIA NSCLC from 1998-2009 was used. Patients receiving any radiation therapy before relapse were excluded. Variables analyzed were age, sex, surgical procedure, extent of lymph node sampling, histology, LVI, tumor size, tumor grade, chemotherapy, nodal stage, and visceral pleural invasion. Cumulative incidence rates were calculated for LR and DR as first sites of failure and Kaplan-Meier estimates for OS. Competing-risk analysis was used to compare times to recurrence events. Multivariate Cox modeling was used to analyze OS. Results: 1,288, 210 and 78 patients were identified with N0, N1, and N2 involvement respectively. 161 patients received chemotherapy. Median follow-up was 28.7 months. Patients with N1 or N2 nodal stage had similar rates of LR as patients with N0 disease, but were both at significantly increased risk for DR (N1, HR = 1.77, p = 0.0012; N2, HR = 2.27, p <0.001) and death (N1, HR = 1.464, p =0.0004; N2, HR = 2.32, p <0.0001). LR was associated with squamous histology, visceral pleural involvement, tumor size and segmentectomy in the Cox model. Conclusions: The risk of LR did not vary substantially in relation to N-stage in our population, though DR did. Although the number of patients with N2 disease was small, these findings call into question the NCCN guidelines. Prospective studies of PORT after R0 resection are needed. N-stage Cumulative Incidence rates (%) Kaplan-Meier estimates (%) Local recurrence Distant recurrence Overall survival 3-year 5-year 3-year 5-year 3-year 5-year N0 13 15 15 17 66 50 N1 19 22 30 38 50 32 N2 16 18 37 42 32 26